The Journal of Immunology · 2002 · 66 citations · 39 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyTumor ImmunologyAntitumor T Cell ResponsesCell-mediated ImmunityCytotoxic T Lymphocyte ResponsesT Cell ActivationT Cell Responses To TumorsTumor-infiltrating LymphocytesCd8 Positive T CellsCd8+ Tumor-infiltrating LymphocytesImmune Effector Cell FunctionLymphocytic ChoriomeningitisT Cell - Mediated RejectionT-cell Mediated RejectionT-cell Responses To Tumor AntigensTumor-specific T Cell Activation
Tumor-specific CD8 T cell responses to MCA102 fibrosarcoma cells expressing the cytotoxic T cell epitope gp33 from lymphocytic choriomeningitis virus were studied. MCA102(gp33) tumors grew progressively in C57BL/6 mice, despite induction of peripheral gp33-tetramer(+) T cells that were capable of mediating antiviral protection, specific cell rejection, and concomitant tumor immunity. MCA102(gp33) tumors were infiltrated with a high number ( approximately 20%) of CD11b(+)CD11c(-) macrophage-phenotype cells that were able to cross-present the gp33 epitope to T cells. Tumor-infiltrating CD8 T cells exhibited a highly activated phenotype but lacked effector cell function. Strikingly, a significant portion of tumor-infiltrating lymphocytes expressed TCRs specific for gp33 but bound MHC tetramers only after cell purification and a 24-h resting period in vitro. The phenomenon of "tetramer-negative T cells" was not restricted to tumor-infiltrating lymphocytes from MCA102(gp33) tumors, but was also observed when Ag-specific T cells derived from an environment with high Ag load were analyzed ex vivo. Thus, using a novel tumor model, allowing us to trace tumor-specific T cells at the single cell level in vivo, we demonstrate that the tumor microenvironment is able to alter the functional activity of T cells infiltrating the tumor mass.
39
Phenotypic Analysis of Antigen-Specific T Lymphocytes
John D. Altman, Paul Moss, Philip Goulder et al. · Science · 1996 · 3.6K citations
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Peter P. Lee, Cassian Yee, Peter A. Savage et al. · Nature Medicine · 1999 · 1.1K citations
Life Sciences, Immunology, Oncology +16